DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
Lancet 1998;
352 (9139): 1498-1504
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.